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OBJECTIVE—The best method to estimate glomerular ﬁltration rate (GFR) in diabetic
patients is still largely debated. We compared the performance of creatinine-based formulas
in a European diabetic population.
RESEARCH DESIGN AND METHODS—We compared the performance of Cockcroft
andGault,simpliﬁedModiﬁcationofDietinRenalDisease(MDRD),andChronicKidneyDisease
Epidemiology (CKD-EPI) Collaboration equations in 246 diabetic patients by calculating the
meanbiasandtheinterquartilerange(IQR)ofthebias,10%(P10)and30%(P30)accuracies,and
Bland-Altman plots. GFR was measured by inulin clearance.
RESULTS—For the whole population, the IQR was slightly lower for CKD-EPI, but the mean
biaswas lower and P10and P30werehigher for MDRD. Similar results were observedinspeciﬁc
subgroups, including patients with mild renal insufﬁciency, obese patients, or type 2 diabetic
patients.
CONCLUSIONS—In our population, the CKD-EPI formula does not exhibit better perfor-
mance than the simpliﬁed MDRD formula for estimating GFR.
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U
sing a creatinine-based formula is
the most common way to evaluate
the glomerular ﬁltration rate (GFR)
inclinicalpractice.However,itcanleadto
an inaccurate evaluation, especially in
patients with normal renal function (1).
A new GFR formula, the Chronic Kidney
Disease Epidemiology (CKD-EPI) Col-
laboration equation, has recently been
developed and has exhibited better per-
formance than the other creatinine-based
formulas in the general population (2).
Therefore,wecomparedtheperformance
oftheCKD-EPIequationtoCockcroftand
Gault (CG) and simpliﬁed Modiﬁcation
of Diet in Renal Disease (MDRD) equa-
tions in a population of diabetic patients.
RESEARCH DESIGN AND
METHODS—The study included 246
nondialyzed diabetic adult patients (59%
men, 95.1% white, 85.8% type 2 diabetic
patients). Mean age was 62.5 6 13.0
years, and mean BMI was 28.8 6 5.0
kg/m
2 (39% of patients had a BMI
.30 kg/m
2). Mean plasma creatinine
(PCr) was 137 6 69 mmol/L, and 60.6%
of the patients had measured GFR
(mGFR) ,60 mL/min/1.73 m
2.
GFR was measured by inulin clear-
ance (Inutest, Fresenius Kabi, Graz, Aus-
tria) using a continuous infusion of inulin
after a loading dose and urine collections.
The clearance value was calculated by the
standard (urinary inulin 3 urine ﬂow)/
plasma inulin (UV/P) formula, and was
normalized to 1.73 m
2 of body surface
area (BSA), calculated according to the
Du Bois formula (3). PCr was assayed
with a kinetic colorimetric-compensated
Jaffe technique (Roche Modular, Meylan,
France).
The following equations were used to
determine estimated GFR (eGFR):
CG = 1.73/BSA 3 [(140 2 age {years}) 3
body weight (kg) 3 k/PCr (mmol/L)]
(4).
MDRD = 186.3 3 [(PCr in mmol/L)/
88.5)]
21.154 3 age in years
20.203 3
0.742 (if female) 3 1.21 (if black)
(5,6).
CKD-EPI = k1 3 [(PCr/88.5)/k2)]
2k3 3
0.993
age,w i t h
–k1 = 141, 143, 163, 166 for white male
and female and black male and female,
respectively;
–k2 = 0.7 or 0.9 for female and male, re-
spectively;
–k3 = 1.209, 0.411, 0.329 for male with
PCr .80 mmol/L, female with PCr
.62 mmol/L, male with PCr #80
mmol/L, and female with PCr #62
mmol/L, respectively (2).
To assess the performance of formu-
las, the correlation coefﬁcient (R
2), the
mean absolute bias (eGFR 2 mGFR),
the interquartile range of the bias (IQR),
and 10% (P10) and 30% (P30) accuracies
were calculated. Bland-Altman plots were
used to show the agreement between
mGFR and eGFR (7). P values , 0.05
were considered signiﬁcant.
RESULTS—For the whole population
of diabetic patients, mean mGFR was
55.4 6 29 mL/min/1.73 m
2. Correlation
between mGFR and eGFR was signiﬁcant
for the three formulas, with R
2 values of
0.728, 0.818, and 0.814 for CG, MDRD,
and CKD-EPI, respectively. Mean abso-
lute bias was 0.8 6 15, 21.2 6 12, and
212.7 6 12 mL/min/1.73 m
2,a n dI Q R
was 16.4, 15.8, and 16 mL/min/1.73 m
2
for CG, MDRD, and CKD-EPI, respectively.
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BRIEF REPORTFigure1showsthe graphic representation
of agreement for each formula according
to the Bland-Altman method. P10 and
P30 were, respectively, 25.6 and 72.8%
for CG, 37.4 and 82.1% for MDRD, and
28 and 80.1% CKD-EPI.
The mean mGFR was 61.2 6 31 and
54.4 6 28 mL/min/1.73 m
2 in type 1 and
2 diabetic patients, respectively. In both
groups of patients, MDRD exhibited the
highest P10 (31.4 and 38.4%) and P30
(85.7 and 81.5%), respectively, com-
p a r e dw i t hC Ga n dC K D - E P I .
The mean mGFR was 36.4 6 13 and
84.6 6 21 mL/min/1.73 m
2 in patients
with GFR ,60 and .60 mL/min/1.73
m
2, respectively. MDRD exhibited the
highest P10 (36.2 and 39.2%) and P30
(75.3 and 91.7%) in both groups com-
p a r e dw i t hC Ga n dC K D - E P I .
Finally, MDRD exhibited the highest
accuracy in nonobese (BMI ,30 kg/m
2,
mGFR = 59.8 6 29) and obese patients
(mGFR = 48.5 6 26), with P10 at 35.3
and 40.6% and P30 at 81.3 and 83.3%,
respectively.
CONCLUSIONS—Our data showed
that the CKD-EPI equation exhibited
similar (or worse) performance than the
simpliﬁed MDRD equation in our popu-
lation of diabetic patients, as well as in
speciﬁc subgroups according to the type
of diabetes, GFR, or presence or not of
obesity. We conﬁrm that the CG formula
is less accurate than the MDRD equation
andshouldnotbeusedtoevaluateGFRin
diabetic patients (8,9). Several authors
have demonstrated better performance
of CKD-EPI compared with MDRD in
thegeneralpopulationand indiabeticpa-
tients (2,10). We are unable to conﬁrm
those results in our population of Euro-
pean diabetic patients. This discrepancy
couldbeattributedtodifferencesbetween
AmericanandEuropeandiabeticpatients,
including a greater proportion of black
patients, a smaller proportion of type 1
diabetic patients, and higher BMIs in
North America (11,12).
The use of a nonenzymatic assay of
PCr and, therefore, the non–re-expressed
MDRD formula, comparatively with the
CKD-EPI study, could be another factor
toexplainthedifference(2,13).However,
values obtained with our compensated
Jaffe method were very similar to those
of an enzymatic method (14). In conclu-
sion, our data suggest that the non–
re-expressed simpliﬁed MDRD formula
can be used in European diabetic patients
to evaluate GFR because the CKD-EPI
Figure 1—Bland-Altman graph shows the agreement between GFR measured by inulin clearance
and GFRestimatedbynormalized CG (A),simpliﬁed MDRD (B),and CKD-EPI (C) equations.The
solid line shows the mean value and the dotted line shows the range of 95% of the values of the bias.
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Rognant and Associatesequation does not seem to exhibit better
performance and is less convenient to use
in clinical practice. However, these results
should be conﬁrmed in larger studies.
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